Dopamine transporter availability in drug-naïve patients with schizophrenia and later psychotic symptoms severity

Schizophr Res. 2017 Dec:190:185-186. doi: 10.1016/j.schres.2017.03.036. Epub 2017 Mar 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / therapeutic use
  • Dopamine Plasma Membrane Transport Proteins / metabolism*
  • Female
  • Humans
  • Male
  • Organotechnetium Compounds / pharmacokinetics
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / diagnostic imaging
  • Psychotic Disorders / etiology*
  • Psychotic Disorders / metabolism*
  • Radiopharmaceuticals / pharmacokinetics
  • Schizophrenia / complications*
  • Schizophrenia / diagnostic imaging
  • Schizophrenia / drug therapy
  • Schizophrenia / metabolism*
  • Tomography, Emission-Computed, Single-Photon
  • Tropanes / pharmacokinetics

Substances

  • Antipsychotic Agents
  • Dopamine Plasma Membrane Transport Proteins
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Tropanes
  • technetium Tc 99m TRODAT-1